Drugmaker GlaxoSmithKline PLC said Tuesday a study shows its human papillomavirus vaccine Cervarix was effective against the types of HPV that are most likely to cause cervical cancer, but also fought other strains of the disease.
GlaxoSmithKline says HPV vaccine worked in studyCourtesy Newsvine - business Tue, 07/07/2009 - 11:37
Drugmaker GlaxoSmithKline PLC said Tuesday a study shows its human papillomavirus vaccine Cervarix was effective against the types of HPV that are most likely to cause cervical cancer, but also fought other strains of the disease. Popular products Tags:
Related itemsPrestige Brands will buy GSK brands for $660M
GSK receives EU approval for prostate drug
Notable Analyst Rating Changes 02/26: RST, AZN/GSK,...
Cherry Wood Finish Adjustable Laptop Notebook...
Canon Pixma MX700 Office All-On-One Inkjet Printer...
|
Popular by tags WeekMonth |
Post new comment